Yoonjung Yoonie Joo

Yoonjung Yoonie Joo

Auto-generated profile, based on publicly available information

Yoonjung Yoonie Joo

Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
HZHana Zouk
Hana Zouk
EVEric Venner
Eric Venner
NLNiall J. Lennon
Niall J. Lennon
DMDonna M. Muzny
Donna M. Muzny
DADebra Abrams
Debra Abrams
RGRichard A. Gibbs
Richard A. Gibbs

1 June 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
YJYoonjung Yoonie Joo
Yoonjung Yoonie Joo
KAKy'Era Actkins
Ky'Era Actkins
JPJennifer A Pacheco
Jennifer A Pacheco
ABAnna O Basile
Anna O Basile
RCRobert Carroll
Robert Carroll
MHM Geoffrey Hayes
M Geoffrey Hayes
Context As many as 75% of patients with polycystic ovary syndrome (PCOS) are estimated to be unidentified in clinical practice. Objective Utilizing polygenic risk prediction, we aim to identify the phenome-wide comorbidity patterns characteristic of PCOS to improve accurate diagnosis and preventive treatment. Design, Patients, and Methods Leveraging the electronic health records (EHRs) of 124 852 individuals, we developed a PCOS risk prediction algorithm by combining polygenic risk scores (PRS) with PCOS component phenotypes into a polygenic and phenotypic risk score (PPRS). We evaluated its predictive capability across different ancestries and perform a PRS-based phenome-wide association study (PheWAS) to assess the phenomic expression of the heightened risk of PCOS. Results The integrated polygenic prediction improved the average performance (pseudo-R2) for PCOS detection by 0.228 (61.5-fold), 0.224 (58.8-fold), 0.211 (57.0-fold) over the null model across European, African, and multi-ancestry participants respectively. The subsequent PRS-powered PheWAS identified a high level of shared biology between PCOS and a range of metabolic and endocrine outcomes, especially with obesity and diabetes: “morbid obesity”, “type 2 diabetes”, “hypercholesterolemia”, “disorders of lipid metabolism”, “hypertension”, and “sleep apnea” reaching phenome-wide significance. Conclusions Our study has expanded the methodological utility of PRS in patient stratification and risk prediction, especially in a multifactorial condition like PCOS, across different genetic origins. By utilizing the individual genome–phenome data available from the EHR, our approach also demonstrates that polygenic prediction by PRS can provide valuable opportunities to discover the pleiotropic phenomic network associated with PCOS pathogenesis.

15 February 2024 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
SLSeungeun Lee
Seungeun Lee
YCYongwon Cho
Yongwon Cho
YJYuyoung Ji
Yuyoung Ji
MJMinhyek Jeon
Minhyek Jeon
AKAram Kim
Aram Kim
YJYoonjung Yoonie Joo
Yoonjung Yoonie Joo

23 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
AMAnubha Mahajan
Anubha Mahajan
CSCassandra N Spracklen
Cassandra N Spracklen
WZWeihua Zhang
Weihua Zhang
MNMaggie Cy Ng
Maggie Cy Ng
LPLauren E Petty
Lauren E Petty
OCon behalf of the DIAMANTE Consortium
on behalf of the DIAMANTE Consortium
We assembled an ancestrally diverse collection of genome-wide association studies of type 2 diabetes (T2D) in 180,834 cases and 1,159,055 controls (48.9% non-European descent). We identified 277 loci at genome-wide significance ( p <5×10 -8 ), including 237 attaining a more stringent trans-ancestry threshold ( p 50% posterior probability. This improved fine-mapping enabled systematic assessment of candidate causal genes and molecular mechanisms through which T2D associations are mediated, laying foundations for functional investigations. Trans-ancestry genetic risk scores enhanced transferability across diverse populations, providing a step towards more effective clinical translation to improve global health.

8 September 2025 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
ELEunji Lee
Eunji Lee
MDMilenna T. van Dijk
Milenna T. van Dijk
BKBo-Gyeom Kim
Bo-Gyeom Kim
GKGakyung Kim
Gakyung Kim
EMEleanor Murphy
Eleanor Murphy
JCJiook Cha
Jiook Cha
A family history of depression is a well-documented risk factor for offspring psychopathology. However, the genetic mechanisms underlying the intergenerational transmission of depression remain unclear. We used genetic, family history, and diagnostic data from 11,875 9–10 year-old children from the Adolescent Brain Cognitive Development study. We estimated and investigated the children’s polygenic scores (PGSs) for 30 distinct traits and their association with a family history of depression (including grandparents and parents) and the children’s overall psychopathology through logistic regression analyses. We assessed the role of polygenic risk for psychiatric disorders in mediating the transmission of depression from one generation to the next. Among 11,875 multi-ancestry children, 8111 participants had matching phenotypic and genotypic data (3832 female [47.2%]; mean (SD) age, 9.5 (0.5) years), including 6151 [71.4%] of European-ancestry). Greater PGSs for depression (estimate = 0.129, 95% CI = 0.070–0.187) and bipolar disorder (estimate = 0.109, 95% CI = 0.051–0.168) were significantly associated with higher family history of depression (Bonferroni-corrected P < 0.05). Depression PGS was the only PGS that significantly associated with both family risk and offspring’s psychopathology, and robustly mediated the impact of family history of depression on several youth psychopathologies including anxiety disorders, suicidal ideation, and any psychiatric disorder (proportions mediated 1.39–5.87% of the total effect on psychopathology; FDR-corrected P < 0.05). These findings suggest that increased polygenic risk for depression partially mediates the associations between family risk for depression and offspring psychopathology, showing a genetic basis for intergenerational transmission of depression. Future approaches that combine assessments of family risk with polygenic profiles may offer a more accurate method for identifying children at elevated risk.

26 April 2022 in Human Brain Mapping
Verified
Journal Article
Open access
KKKakyeong Kim
Kakyeong Kim
YJYoonjung Yoonie Joo
Yoonjung Yoonie Joo
GAGun Ahn
Gun Ahn
HWHee‐Hwan Wang
Hee‐Hwan Wang
SMSeo‐Yoon Moon
Seo‐Yoon Moon
JCJiook Cha
Jiook Cha
Sex impacts the development of the brain and cognition differently across individuals. However, the literature on brain sex dimorphism in humans is mixed. We aim to investigate the biological underpinnings of the individual variability of sexual dimorphism in the brain and its impact on cognitive performance. To this end, we tested whether the individual difference in brain sex would be linked to that in cognitive performance that is influenced by genetic factors in prepubertal children (N = 9,658, ages 9–10 years old; the Adolescent Brain Cognitive Development study). To capture the interindividual variability of the brain, we estimated the probability of being male or female based on the brain morphometry and connectivity features using machine learning (herein called a brain sex score). The models accurately classified the biological sex with a test ROC–AUC of 93.32%. As a result, a greater brain sex score correlated significantly with greater intelligence (pfdr < .001, = .011–.034; adjusted for covariates) and higher cognitive genome‐wide polygenic scores (GPSs) (pfdr < .001, < .005). Structural equation models revealed that the GPS‐intelligence association was significantly modulated by the brain sex score, such that a brain with a higher maleness score (or a lower femaleness score) mediated a positive GPS effect on intelligence (indirect effects = .006–.009; p = .002–.022; sex‐stratified analysis). The finding of the sex modulatory effect on the gene–brain–cognition relationship presents a likely biological pathway to the individual and sex differences in the brain and cognitive performance in preadolescence.